Randomized Clinical Controlled Assessment of Ashwagandhadi Choorna in comparison to Thyroxine Sodium Tablet in the Management of Galganda (Hypothyroidism).
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 84
- 试验地点
- 1
- 主要终点
- 2. To observe the changes in TSH level.
研究概览
简要总结
The current study aimed as Randomized Clinical Controlled Assessment Of Ashwagandhadi Choorna In Comparison To Thyroxine Sodium Tablet In The Management Of Galganda (Hypothyroidism).
The symptoms of Hypothyroidism are Weight gain, Loss of appetite , Oligomenorrhoea, Dryness of skin, Loss of hairs, Dyspnoea etc. Ashwagandhadi choorna 12gm (one karsha ) is given in the morning empty stomach as experimental group medicine in two divided doses. It will be given for 3 months. Tab Thyroxine sodium is used as control group medicine for 3 months. Assessment for both will be done at 0th day, 45th Day 90th day. Assessment done on the basis of subjective criteria and Objective criterias.
Clinical assessment is done after every 45th day.
Hypothyroidism is one of the most common Thyroid disorders in India affecting one in 10 adults. In ayurveda parlance, this is attributed as the function of Agni (system related to metabolism ).In modern science, the treatment of Hypothyroidism is done by Thyroxine Harmone therapy for long time but this medication Ashwagandhadi Choorna has Deepan , Pachan quality which pops by metabolism and also have Thyroid stimulatory properties.
The Content of Ashwagandhadi Choorna is easily available and cost effective in nature hence selected for the present study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Serum Ultrasensitive level 15-20 micro IU/ML 2.Newly diagnosed cases of hypothyroidism less than Six months ago.
- •3.Subject having one or more classical symptoms.
- •4.Patient of either gender.
- •5.Age 18 years and 40 years.
排除标准
- •1.Immunocompromised patients or patients on immunosuppressive drugs.
- •2.Patients suffering from life threatening diseases.
- •3.Pregnancy and lactating mother.
- •4.K/C/O Thyroid Neoplasia.
- •5.Progressive cases of Myxedema coma.
- •6.Patients of Subclinical Hypothyroidism.
结局指标
主要结局
2. To observe the changes in TSH level.
时间窗: 3 months
1. To assess the symptomatic relief.
时间窗: 3 months
次要结局
- To study the Probable mode of action of Ashwagandhadi Churna in(management of Hypothyroidism.)